Skip to content

a study to evaluate efficacy of serratus anterior plane block in modified radical mastectomy surgeries

A Prospective randomized study to evaluate efficacy of Serratus Anterior Plane block in addition to multimodal analgesia for perioperative opioid sparing in patients undergoing modified radical mastectomy - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081732
Enrollment
60
Registered
2025-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: gabapentin plus usg guided serratus anterior plane block: Oral Gabapentin 400mg 2 hours prior to surgeryas a single dose in 24 hours, plus single shot USG guided Serratus Anterior Plane

Sponsors

Nizams Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 & 2 Patients with carcinoma breast posted for modified radical mastectomy

Exclusion criteria

Exclusion criteria: ASA 3 and above patients, denial of consent for the procedure, previous allergic history to anaesthetic drugs, coagulopathy, patients with fungating breast malignancy with distant metastasis, patients on anticoagulation, pregnant women, gross abnormality in the anatomy of chest wall due to malignancy, severe cardiac, respiratory and neurological dysfunction

Design outcomes

Primary

MeasureTime frame
compare postoperative opioid consumption requirement between the groupsTimepoint: at 1hr, 2hr, 6hr, 12hr, 24hr after surgery.

Secondary

MeasureTime frame
incidence of postoperative nausea and vomiting(PONV), time to first opioid demand, functional activity score at rest and on arm abduction.Timepoint: at 1hr, 2hr, 6hr, 12hr, 24hr after surgery.

Countries

India

Contacts

Public ContactSrikanth Kakunoor

Nizams Institute of Medical Sciences

drshibanipadhy@gmail.com8332921975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026